Form EFFECT INNOCAN PHARMA Corp
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 5:00 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PhotoGPT Expands AI E-Commerce Visual Platform with Batch Photo Editor, AI Product Detail Page Generator, AI Product Photography, and AI Video Ad Generator
- IP Strategy Receives Nasdaq Notification Regarding Delayed Form 10-Q Filing
- Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
